Novo Nordisk A/S Common Stock (NVO)
Other Income/Expenses (Net)
kr 6.65B
TTM · Period ending: · DKK
NVO Other Income/Expenses (Net)
Latest reportedkr 6.65B DKKperiod ending
Latest reportedkr 6.65B DKKperiod ending
NVO TTM Other Income/Expenses (Net) · DKK (-kr 675.91M → kr 6.65B)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
NVO other income/expenses (net) history
Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (DKK) |
|---|---|
| -12,030,802,000 | |
| -12,769,939,000 | |
| -12,986,475,000 | |
| -15,625,684,000 | |
| -6,104,252,000 | |
| -4,642,014,000 | |
| -3,710,387,000 | |
| -4,509,265,000 | |
| -3,720,859,000 | |
| -3,266,375,000 | |
| -2,827,764,000 | |
| -3,833,227,000 | |
| -3,114,304,000 | |
| -2,670,895,000 | |
| -2,105,362,000 | |
| -3,345,143,000 | |
| -2,698,336,000 | |
| -2,081,223,000 | |
| -1,888,825,000 | |
| -2,181,770,000 | |
| -1,730,696,000 | |
| -1,796,429,000 | |
| -1,732,312,000 | |
| -2,041,296,000 | |
| -2,198,290,000 | |
| -2,048,003,000 | |
| -1,788,707,000 | |
| -2,949,117,000 | |
| -2,705,329,000 | |
| -2,285,815,000 | |
| -1,800,719,000 | |
| -1,962,821,000 | |
| -1,397,315,000 | |
| -1,203,043,000 | |
| -1,238,597,000 | |
| -2,555,567,000 | |
| -2,382,759,000 | |
| -1,822,486,000 | |
| -1,437,031,000 | |
| -1,964,588,000 | |
| -1,601,190,000 | |
| -1,383,868,000 | |
| -1,048,009,000 | |
| -1,577,244,000 | |
| -1,295,589,000 | |
| -1,021,075,000 | |
| -1,056,357,000 | |
| -2,422,975,000 | |
| -1,995,457,000 | |
| -1,625,414,000 | |
| -837,029,000 | |
| -897,933,000 | |
| -848,901,000 | |
| -629,340,000 | |
| -669,796,000 | |
| -1,192,404,000 | |
| -935,746,000 | |
| -878,194,000 | |
| -675,905,000 | |
| -766,321,000 | |
| -737,590,500 |